Tiina Talaslahti
Overview
Explore the profile of Tiina Talaslahti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palm A, Talaslahti T, Vataja R, Ginters M, Kautiainen H, Elonheimo H, et al.
Eur Arch Psychiatry Clin Neurosci
. 2024 Apr;
275(2):463-471.
PMID: 38613687
Background: Chronic heavy alcohol use may lead to permanent brain damage, cognitive impairment, and dementia. While the link between alcohol use and crime is strong, virtually no research exists on...
2.
Talaslahti T, Ginters M, Palm A, Kautiainen H, Vataja R, Elonheimo H, et al.
Eur Psychiatry
. 2024 Jan;
67(1):e10.
PMID: 38228325
Background: Neuropsychiatric symptoms in major neurocognitive disorders have been strongly associated with suicidality. Methods: The objectives were to explore suicide rates in degenerative neurocognitive disorders (DNDs), alcohol-related neurocognitive disorders (ARNDs),...
3.
von Knorring J, Baryshnikov I, Jylha P, Talaslahti T, Heikkinen M, Isometsa E
BMC Psychiatry
. 2023 Nov;
23(1):888.
PMID: 38017416
Background: Despite numerous national depression care guidelines (DCGs), suboptimal antidepressant treatment may occur. We examined DCG concordance and depression treatment outcomes in psychiatric settings. Methods: We evaluated treatment received and...
4.
Palm A, Talaslahti T, Vataja R, Ginters M, Kautiainen H, Elonheimo H, et al.
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445298
Background: Research on the use of psychotropic drugs in people with alcohol-related neurocognitive disorders is virtually nonexistent. We examined the prevalence of antipsychotic drug use and its effect on mortality...
5.
Criminal Behaviour After Diagnosis of a Neurocognitive Disorder: A Nationwide Finnish Register Study
Ginters M, Talaslahti T, Palm A, Kautiainen H, Vataja R, Elonheimo H, et al.
Am J Geriatr Psychiatry
. 2023 Mar;
31(8):598-606.
PMID: 36872165
Objective: To explore criminal behavior of individuals with Alzheimer's disease (AD), frontotemporal dementia (FTD), or Lewy body dementias (LBD) after the diagnosis. Design: Nationwide register study. Setting: Information on diagnoses...
6.
Talaslahti T, Ginters M, Kautiainen H, Vataja R, Palm A, Elonheimo H, et al.
Int J Methods Psychiatr Res
. 2022 Sep;
32(2):e1948.
PMID: 36178374
Objectives: To explore mortality of patients with Alzheimer's disease (AD), frontotemporal dementia (FTD), or Lewy body dementias (LBD) who had criminal behavior in the year preceding diagnosis. Methods: Data were...
7.
Palm A, Vataja R, Talaslahti T, Ginters M, Kautiainen H, Elonheimo H, et al.
Int J Geriatr Psychiatry
. 2022 Jul;
37(8).
PMID: 35789035
Background: Epidemiological data on alcohol-related cognitive disorders are scarce. Up-to-date population-based incidence and mortality rates for Wernicke-Korsakoff syndrome (WKS) and alcohol-related dementia (ARD) are necessary to understand the burden of...
8.
Talaslahti T, Ginters M, Kautiainen H, Vataja R, Elonheimo H, Erkinjuntti T, et al.
Am J Geriatr Psychiatry
. 2020 Dec;
29(7):657-665.
PMID: 33334647
Objective: To explore the criminality of patients with subsequent diagnosis of Alzheimer's disease (AD), frontotemporal dementia (FTD), or Lewy body dementias (LBD) in the four years preceding diagnosis. Design: Nationwide...
9.
Talaslahti T, Alanen H, Hakko H, Isohanni M, Kampman O, Hakkinen U, et al.
Int J Geriatr Psychiatry
. 2015 Jul;
31(4):355-60.
PMID: 26223648
Objective: In this register-based study the rates and durations of psychiatric hospitalizations were compared between patients with very-late-onset schizophrenia-like psychosis (VLOSLP, n = 918) and elderly patients with illness onset...
10.
Talaslahti T, Alanen H, Hakko H, Isohanni M, Hakkinen U, Leinonen E
Int J Geriatr Psychiatry
. 2014 Jul;
30(5):453-9.
PMID: 24990229
Objective: In this register-based study of schizophrenia patients aged 65 years or above, mortality and causes of death diagnosed at age of 60+ (very-late-onset schizophrenia-like psychosis, VLOSLP) were studied in...